The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1. [electronic resource]
Producer: 19991028Description: 686-90 p. digitalISSN:- 0015-0282
- Anti-HIV Agents -- pharmacology
- Cell Survival
- HIV Infections -- prevention & control
- HIV-1 -- drug effects
- Humans
- Male
- Nonoxynol -- pharmacology
- Plant Proteins -- pharmacology
- Prospective Studies
- Ribosome Inactivating Proteins, Type 1
- Ribosome Inactivating Proteins, Type 2
- Sexually Transmitted Diseases, Viral -- prevention & control
- Sperm Motility -- drug effects
- Spermatocidal Agents -- pharmacology
- Spermatozoa -- drug effects
- Staining and Labeling
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.